Methodology

DOACs in the treatment of cancer-associated thrombosis
Methodology

DOACs in the treatment of cancer-associated thrombosis

Since the publication of the SELECT-D trial and the Hokusai-VTE Cancer study, there has been a shift in the treatment of cancer-associated thrombosis.

Read More
Bleeding complications and platelet dysfunction in patients with lymphoproliferative disease receiving Bruton tyrosine kinase inhibitors
Methodology

Bleeding complications and platelet dysfunction in patients with lymphoproliferative disease receiving Bruton tyrosine kinase inhibitors

Ibrutinib is an irreversible inhibitor of Bruton tyrosine kinase (Btk) that is approved for the treatment of chronic lymphocytic leukemia and indolent non-Hodgkin lymphomas...

Read More